Fierce Biotech: Trialbee adds ex-Lundbeck CEO, Bristol-Myers exec to board

Social_1200x630_Adds new board members

Fierce Biotech: Trialbee adds ex-Lundbeck CEO, Bristol-Myers exec to board

Trialbee has added a pair of biopharma heavyweights to its board of directors. Read more in this article from Fierce Biotech.

For more information, request a demo of this solution.

}

August 26, 2016

m

News

← PREVIOUS NEXT →

RECENT POSTS

Trialbee Poised to Accelerate Growth with Data-Driven Solutions for Patient Recruitment Challenges

Trialbee Poised to Accelerate Growth with Data-Driven Solutions for Patient Recruitment Challenges

CHAPEL HILL, NC AND MALMÖ, Sweden – (January 26,...

Bringing New Technology Approaches to Clinical Trial Recruitment

Bringing New Technology Approaches to Clinical Trial Recruitment

As Trialbee seeks to continue to innovate in...

Clinical Trial Recruitment in 2022: A Year of Transformation

Clinical Trial Recruitment in 2022: A Year of Transformation

The past year brought many changes for Trialbee....

Disrupt Clinical Trial Enrollment: Patient-Centered Technology Approaches to Recruitment

Disrupt Clinical Trial Enrollment: Patient-Centered Technology Approaches to Recruitment

Duration: 30...

COVID-19 Vaccine Development

COVID-19 Vaccine Development